Oryzon Genomics SA (ORY) — Cash Flow Reinvestment Rate
Oryzon Genomics SA (ORY) has a Cash Flow Reinvestment Rate of 0.17x as of December 2015, reinvesting €87.70K (capex €87.70K ) from operating cash flow of €523.10K. Check Oryzon Genomics SA cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oryzon Genomics SA Cash Flow Reinvestment Rate (2013–2015)
Historical reinvestment intensity for Oryzon Genomics SA across 3 annual periods. Explore how much of Oryzon Genomics SA's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Oryzon Genomics SA (2013–2015)
Year-by-year capital reinvestment analysis for Oryzon Genomics SA. For live market cap and broader valuation context, see ORY market cap.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2015 | 6.74x | €3.53 Million | €523.14K | €87.65K | ▲ +2244.9% |
| 2014 | 0.29x | €3.49 Million | €12.13 Million | €47.00K | ▼ 0.0% |
| 2013 | 0.29x | €3.49 Million | €12.13 Million | €47.30K | — |